Pierzynowska, Karolina
Gaffke, Lidia
Hać, Aleksandra
Mantej, Jagoda
Niedziałek, Natalia
Brokowska, Joanna
Węgrzyn, Grzegorz http://orcid.org/0000-0003-4042-7466
Funding for this research was provided by:
Uniwersytet Gdanski (538-L140-B258-16)
Article History
Received: 4 July 2017
Accepted: 8 February 2018
First Online: 12 February 2018
Compliance with ethical standards
:
: The use of genistein in treatment of Huntington’s disease is a subject of patent application (No. P.417983, submitted to Polish Patent Office). No other conflicts of interest are declared by the authors.